Tirzepatide studies: 457 papers with results
Page 3 of 10
- Predictors of Initial and Sustained Glycemic and Weight Response to Tirzepatide: A Post Hoc Analysis of SURPASS-4.
Pearson ER · Diabetes · 2025
Randomized controlled trial · 8 results
- Early-Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials.
Gourgari E · Obesity (Silver Spring, Md.) · 2025
Randomized controlled trial · 6 results
- Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis.
Onishi Y · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
Randomized controlled trial · 9 results
- Effects of Tirzepatide Versus Basal Insulins in People With Type 2 Diabetes and Different Baseline Glycemic Patterns: Post Hoc Analyses of the SURPASS-3 and SURPASS-4 Trials.
Giorgino F · Diabetes care · 2024
Randomized controlled trial · 7 results
- People With Lowest Physical Functioning Scores Showed Greatest Improvement After Tirzepatide Treatment.
Li X · Obesity (Silver Spring, Md.) · 2026
Randomized controlled trial · 6 results
- Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis.
Aronne LJ · The American journal of medicine · 2026
Randomized controlled trial · 12 results
- Association of tirzepatide with changes in OSA-related measures based on baseline characteristics - post hoc analyses of SURMOUNT-OSA.
Falcon B · Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026
Randomized controlled trial · 9 results
- Achieving the triple endpoint of body weight reduction thresholds, systolic blood pressure reduction ≥5 mmHg and non-HDL cholesterol <130 mg/dL with tirzepatide in people with obesity: A post hoc analysis from the SURMOUNT trials.
Sattar N · PloS one · 2026
Randomized controlled trial · 3 results
- Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1.
Sattar N · Journal of endocrinological investigation · 2026
Randomized controlled trial · 4 results
- Safety and efficacy of switching from dulaglutide to tirzepatide across clinically relevant baseline characteristics in participants with T2D: subgroup analysis of SURPASS-SWITCH.
Violante-Ortiz R · BMJ open diabetes research & care · 2026
Randomized controlled trial · 10 results
- Comparative Efficacy of Tirzepatide Versus Semaglutide for Weight Loss in Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis of Head-to-Head Studies.
Paccola GP · Clinical obesity · 2026
Systematic review · 13 results
- Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
Karagiannis T · Diabetologia · 2024
Systematic review · 18 results
- Dose-response analysis of tirzepatide and acute pancreatitis: An international systematic review and quantitative meta-analysis of randomised trials.
Benny O · Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2026
Systematic review · 5 results
- Tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis.
Kamrul-Hasan ABM · Endocrinology and metabolism (Seoul, Korea) · 2025
Systematic review · 10 results
- The adverse effects associated with tirzepatide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis.
Sillassen CDB · BMC medicine · 2026
Systematic review · 7 results
- Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis.
Sattar N · Nature medicine · 2022
Systematic review · 4 results
- Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.
Karagiannis T · Diabetologia · 2022
Systematic review · 14 results
- Efficacy and safety of tirzepatide in patients with type 2 diabetes: A systematic review and meta-analysis.
Tang Y · Frontiers in pharmacology · 2022
Systematic review · 12 results
- Weight Loss Efficacy of Tirzepatide Compared to Placebo or GLP-1 Receptor Agonists in Adults With Obesity or Overweight: A Meta-Analysis of Randomized Controlled Trials With ≥ 20 Weeks Treatment Duration.
Khawaji A · Journal of obesity · 2025
Systematic review · 6 results
- Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis.
Tan B · International journal of obesity (2005) · 2023
Systematic review · 8 results
- Tirzepatide on physical function in adults with overweight or obesity: A systematic review and meta-analysis.
Schmidt PHS · Diabetes, obesity & metabolism · 2026
Systematic review · 4 results
- Once-Weekly Tirzepatide Versus Once-Daily Basal Insulin in Managing Type 2 Diabetes Inadequately Controlled With Oral anti-Hyperglycemic Drugs: A Systematic Review and Meta-Analysis.
Kamrul-Hasan ABM · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
Systematic review · 12 results
- Comparative Efficacy and Safety of Tirzepatide in Asian and Non-Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta-Analysis.
Kamrul-Hasan ABM · Endocrinology, diabetes & metabolism · 2026
Systematic review · 6 results
- Efficacy and Safety of Novel Twincretin Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, as an Anti-obesity Medicine in Individuals Without Diabetes: A Systematic Review and Meta-analysis.
Dutta D · TouchREVIEWS in endocrinology · 2024
Systematic review · 7 results
- Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials.
Moiz A · Annals of internal medicine · 2025
Systematic review · 8 results
- A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults.
McGowan B · Nature medicine · 2025
Systematic review · 13 results
- Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials.
de Mesquita YLL · International journal of obesity (2005) · 2023
Systematic review · 11 results
- Evidence that tirzepatide protects against diabetes-related cardiac damages.
Taktaz F · Cardiovascular diabetology · 2024
Systematic review · 5 results
- Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials.
Xie Z · Metabolism: clinical and experimental · 2024
Systematic review · 32 results
- Meta-analysis of head-to-head clinical trials comparing incretin-based glucose-lowering medications and basal insulin: An update including recently developed glucagon-like peptide-1 (GLP-1) receptor agonists and the glucose-dependent insulinotropic polypeptide/GLP-1 receptor co-agonist tirzepatide.
Nauck MA · Diabetes, obesity & metabolism · 2023
Systematic review · 2 results
- Tirzepatide use and the risk of cancer among individuals with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
Popovic DS · Diabetes research and clinical practice · 2024
Systematic review · 2 results
- Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Suboptimal Initial Clinical Response and Weight Gain Recurrence After Bariatric Surgery: a Systematic Review and Meta-analysis.
Nie Y · Obesity surgery · 2025
Systematic review · 11 results
- Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis.
Liu S · Frontiers in endocrinology · 2025
Systematic review · 12 results
- The efficacy and safety of glucagon-like peptide-1 receptor agonists in non-diabetic adults with overweight/obesity: An umbrella review of systematic reviews and meta-analyses.
Zamanian N · European journal of pharmacology · 2025
Systematic review · 5 results
- Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis.
Bayoumy AB · Journal of Crohn's & colitis · 2025
Systematic review · 12 results
- Comparative Effectiveness of Glucagon-like Peptide-1- Receptor Agonists in Patients With Heart Failure With Preserved or Minimally Reduced Ejection Fraction: A Comprehensive Bayesian Network Meta-Analysis and Network Meta-Regression.
Khalil I · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
Systematic review · 14 results
- Efficacy and safety of European Medicines Agency (EMA)-approved pharmacological, endoscopic, and surgical treatments in different classes of obesity: A network meta-analysis of randomised controlled trials for the development of the SIO (Società Italiana Obesità) Italian guidelines for the diagnosis and treatment of overweight and obesity.
Barazzoni R · Diabetes, obesity & metabolism · 2026
Systematic review · 8 results
- Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta-analysis of randomized clinical trials.
Ayesh H · Diabetes, obesity & metabolism · 2024
Systematic review · 7 results
- Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Eisa N · Diabetes, obesity & metabolism · 2026
Systematic review · 5 results
- Cardiovascular Outcomes in Adults With Type 2 Diabetes Treated With Tirzepatide: A Systematic Review and Meta-Analysis of Real-World Studies.
Kamrul-Hasan ABM · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2026
Systematic review · 14 results
- Approved weight loss drugs for obesity with a thorough emphasis on GLP-1 agonist medications: A systematic review.
Gunasekaran P · Disease-a-month : DM · 2026
Systematic review · 33 results
- Comparison of pharmacotherapies for obesity with sleeve gastrectomy: a network meta-analysis and systematic review.
Omeh Z · Expert review of endocrinology & metabolism · 2026
Systematic review · 5 results
- Histological efficacy of anti-diabetic agents in MASH and the mediating role of weight loss: A network meta-analysis.
Banerjee M · Diabetes, obesity & metabolism · 2026
Systematic review · 8 results
- Cardiovascular Outcomes With Tirzepatide Versus GLP-1 Receptor Agonists in Overweight or Obesity: A Systematic Review and Meta-Analysis.
Silva JPMRJ · Diabetes, obesity & metabolism · 2026
Systematic review · 5 results
- Efficacy of tirzepatide in glycemic control and weight management in adults with type 2 diabetes: a systematic review and meta-analysis of real-world studies.
Kamrul-Hasan ABM · Postgraduate medical journal · 2026
Systematic review · 10 results
- Preferred Glucagon-like Peptide-1 Receptor Agonists in Adults With Type 2 Diabetes and Established Cardiovascular Disease or High Cardiovascular Risk: A Network Meta-analysis of Randomized Trials.
Abomohsen M · Canadian journal of diabetes · 2026
Systematic review · 13 results
- Evaluation and comparison of efficacy and safety of tirzepatide and semaglutide in patients with type 2 diabetes mellitus: A Bayesian network meta-analysis.
Ding Y · Pharmacological research · 2024
Systematic review · 48 results
- Tirzepatide, cardiovascular outcomes and mortality in obesity and diabetes: a systematic review and meta-analysis.
Spiazzi BF · Diabetes research and clinical practice · 2026
Systematic review · 5 results
- Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Direct Comparative Studies.
Wen J · Endocrinology, diabetes & metabolism · 2025
Systematic review · 5 results
- Cardiometabolic risk effects of weight-loss medications: An updated network meta-analysis.
Wang J · Diabetes, obesity & metabolism · 2025
Systematic review · 9 results